Replies to post #65728 on NanoViricides Inc. (NNVC)

[JG36]

The original study you cited was for oncology costs

False. My first number was from a misquote of a study that covered a wide variety of conditions, not just cancer. In particular the correct $19,320 number is an average phase 3 per subject cost for all the fields of medicine they looked at, including things like rheumatology and psychiatry. You have oncology on the brain.